These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23103473)

  • 1. Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis.
    Strack AM; Carballo-Jane E; Wang SP; Xue J; Ping X; McNamara LA; Thankappan A; Price O; Wolff M; Wu TJ; Kawka D; Mariano M; Burton C; Chang CH; Chen J; Menke J; Luell S; Zycband EI; Tong X; Raubertas R; Sparrow CP; Hubbard B; Woods J; O'Neill G; Waters MG; Sitlani A
    J Lipid Res; 2013 Jan; 54(1):177-88. PubMed ID: 23103473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niacin and biosynthesis of PGD₂by platelet COX-1 in mice and humans.
    Song WL; Stubbe J; Ricciotti E; Alamuddin N; Ibrahim S; Crichton I; Prempeh M; Lawson JA; Wilensky RL; Rasmussen LM; Puré E; FitzGerald GA
    J Clin Invest; 2012 Apr; 122(4):1459-68. PubMed ID: 22406532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.
    Cheng K; Wu TJ; Wu KK; Sturino C; Metters K; Gottesdiener K; Wright SD; Wang Z; O'Neill G; Lai E; Waters MG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6682-7. PubMed ID: 16617107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid.
    Mateuszuk L; Jasztal A; Maslak E; Gasior-Glogowska M; Baranska M; Sitek B; Kostogrys R; Zakrzewska A; Kij A; Walczak M; Chlopicki S
    J Pharmacol Exp Ther; 2016 Feb; 356(2):514-24. PubMed ID: 26631491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-atherosclerotic effects of pravastatin in brachiocephalic artery in comparison with en face aorta and aortic roots in ApoE/LDLR
    Kostogrys RB; Franczyk-Zarow M; Gasior-Glogowska M; Kus E; Jasztal A; Wrobel TP; Baranska M; Czyzynska-Cichon I; Drahun A; Manterys A; Chlopicki S
    Pharmacol Rep; 2017 Feb; 69(1):112-118. PubMed ID: 27915184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
    Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
    Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
    Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the Mir-106b~ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice.
    Semo J; Chernin G; Jonas M; Shimoni S; George J
    Lipids Health Dis; 2019 Dec; 18(1):208. PubMed ID: 31796057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DP1 receptor agonist, BW245C inhibits diet-induced obesity in ApoE
    Kumar S; Palaia T; Hall C; Ragolia L
    Obes Res Clin Pract; 2018; 12(2):229-241. PubMed ID: 28602634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
    Xu J; Ma C; Chen M; Rong S; Gao H; Xia Z; Huang F
    Lipids Health Dis; 2018 Jul; 17(1):182. PubMed ID: 30064511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque.
    Trusca VG; Fuior EV; Gafencu AV
    Curr Mol Med; 2015; 15(10):905-31. PubMed ID: 26592248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of lipids in atherosclerotic lesion in aorta from ApoE/LDLR-/- mice by FT-IR spectroscopy and Hierarchical Cluster Analysis.
    P Wrobel T; Mateuszuk L; Chlopicki S; Malek K; Baranska M
    Analyst; 2011 Dec; 136(24):5247-55. PubMed ID: 22007352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical assessment of the quantification of atherosclerotic lesions in apoE⁻/⁻ mice.
    Lin Y; Bai L; Chen Y; Zhu N; Bai Y; Li Q; Zhao S; Fan J; Liu E
    Mol Med Rep; 2015 Oct; 12(4):5298-306. PubMed ID: 26239265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol effects on endoglin and its downstream pathways in ApoE/LDLR double knockout mice.
    Strasky Z; Vecerova L; Rathouska J; Slanarova M; Brcakova E; Kudlackova Z; Andrys C; Micuda S; Nachtigal P
    Circ J; 2011; 75(7):1747-55. PubMed ID: 21576826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexim1 heterozygosity stabilizes atherosclerotic plaque and decreased steatosis in ApoE null mice fed atherogenic diet.
    Dhar-Mascareno M; Rozenberg I; Iqbal J; Hussain MM; Beckles D; Mascareno E
    Int J Biochem Cell Biol; 2017 Feb; 83():56-64. PubMed ID: 28013147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
    Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice.
    Sagawa Y; Sato M; Sakai N; Chikahisa S; Chiba S; Maruyama T; Yamamoto J; Nishino S
    Neuropharmacology; 2016 Nov; 110(Pt A):268-276. PubMed ID: 27474349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats.
    Zhao Y; Yang Y; Xing R; Cui X; Xiao Y; Xie L; You P; Wang T; Zeng L; Peng W; Li D; Chen H; Liu M
    Atherosclerosis; 2018 Apr; 271():26-35. PubMed ID: 29459263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
    Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
    J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.